Boston Scientific Corp

詳細情報企業名

企業情報

企業コードBSX

会社名Boston Scientific Corp

上場日May 19, 1992

最高経営責任者「CEO」Mr. Michael F. (Mike) Mahoney

従業員数53000

証券種類Ordinary Share

決算期末May 19

本社所在地300 Boston Scientific Way

都市MARLBOROUGH

証券取引所NYSE Consolidated

国United States of America

郵便番号01752-1234

電話番号15086834000

ウェブサイトhttps://www.bostonscientific.com/en-US/Home.html

企業コードBSX

上場日May 19, 1992

最高経営責任者「CEO」Mr. Michael F. (Mike) Mahoney

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Michael F. (Mike) Mahoney

Chairman of the Board, President, Chief Executive Officer

1.75M

-3.25%

Mr. John E. Sununu

Independent Director

54.72K

+3.95%

Mr. David S. (Dave) Wichmann

Independent Director

41.58K

+5.27%

Ms. Ellen M. Zane

Independent Director

37.02K

+5.96%

Mr. Jonathan R. Monson

Chief Financial Officer, Executive Vice President

35.29K

+1.62%

Mr. Vance R. Brown

Senior Vice President, General Counsel, Corporate Secretary

33.45K

+6.64%

Mr. David C. Habiger

Independent Director

5.63K

+58.67%

Mr. Yoshiaki Fujimori

Independent Director

2.08K

-58.23%

Mr. Arthur Crosswell Butcher

Executive Vice President, Group President, MedSurg and Asia Pacific

--

Mr. Edward J. Ludwig

Lead Independent Director

--

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Michael F. (Mike) Mahoney

Chairman of the Board, President, Chief Executive Officer

1.75M

-3.25%

Mr. John E. Sununu

Independent Director

54.72K

+3.95%

Mr. David S. (Dave) Wichmann

Independent Director

41.58K

+5.27%

Ms. Ellen M. Zane

Independent Director

37.02K

+5.96%

Mr. Jonathan R. Monson

Chief Financial Officer, Executive Vice President

35.29K

+1.62%

Mr. Vance R. Brown

Senior Vice President, General Counsel, Corporate Secretary

33.45K

+6.64%

収益内訳

通貨: USD更新時刻: Sun, Jul 6

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

事業別USD

会社名

収益

比率

Electrophysiology

730.00M

15.66%

Interventional Cardiology Therapies

697.00M

14.95%

Endoscopy

673.00M

14.43%

Peripheral Interventions

656.00M

14.07%

Urology

633.00M

13.57%

他の

1.27B

27.32%

地域別USD

会社名

収益

比率

United States

2.96B

63.48%

EMEA (Europe, Middle East and Africa)

846.00M

18.14%

Asia Pacific

701.00M

15.03%

Latin America and Canada

155.00M

3.32%

事業別

地域別

事業別USD

会社名

収益

比率

Electrophysiology

730.00M

15.66%

Interventional Cardiology Therapies

697.00M

14.95%

Endoscopy

673.00M

14.43%

Peripheral Interventions

656.00M

14.07%

Urology

633.00M

13.57%

他の

1.27B

27.32%

株主

更新時刻: Sat, Aug 16

株主統計

種類

株主統計

比率

The Vanguard Group, Inc.

9.21%

Fidelity Management & Research Company LLC

6.71%

BlackRock Institutional Trust Company, N.A.

5.28%

State Street Global Advisors (US)

4.40%

PRIMECAP Management Company

2.34%

他の

72.06%

株主統計

比率

The Vanguard Group, Inc.

9.21%

Fidelity Management & Research Company LLC

6.71%

BlackRock Institutional Trust Company, N.A.

5.28%

State Street Global Advisors (US)

4.40%

PRIMECAP Management Company

2.34%

他の

72.06%

種類

株主統計

比率

Investment Advisor

51.04%

Investment Advisor/Hedge Fund

29.03%

Hedge Fund

4.14%

Pension Fund

2.73%

Research Firm

2.53%

Bank and Trust

2.05%

Sovereign Wealth Fund

1.54%

Family Office

0.23%

Private Equity

0.21%

他の

6.51%

機関投資家保有株

更新時刻: Tue, Jul 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q2

2752

1.39B

93.57%

+165.36K

2025Q1

2744

1.39B

93.81%

-5.31M

2024Q4

2559

1.38B

93.61%

+1.09M

2024Q3

2417

1.37B

92.76%

-24.32M

2024Q2

2341

1.37B

93.29%

-18.17M

2024Q1

2227

1.37B

93.23%

-40.14M

2023Q4

2171

1.39B

94.95%

-25.34M

2023Q3

2110

1.39B

95.17%

-6.29M

2023Q2

2081

1.38B

95.67%

-15.63M

2023Q1

2012

1.36B

94.85%

-23.81M

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

The Vanguard Group, Inc.

133.95M

9.05%

+1.70M

+1.28%

Mar 31, 2025

Fidelity Management & Research Company LLC

117.45M

7.94%

-3.75M

-3.09%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

77.81M

5.26%

+1.08M

+1.41%

Mar 31, 2025

State Street Global Advisors (US)

64.48M

4.36%

+514.79K

+0.80%

Mar 31, 2025

PRIMECAP Management Company

36.50M

2.47%

-432.72K

-1.17%

Mar 31, 2025

Wellington Management Company, LLP

33.20M

2.24%

-2.97M

-8.21%

Mar 31, 2025

Geode Capital Management, L.L.C.

31.80M

2.15%

+1.18M

+3.84%

Mar 31, 2025

Capital World Investors

28.56M

1.93%

+658.82K

+2.36%

Mar 31, 2025

Managed Account Advisors LLC

21.29M

1.44%

+3.60M

+20.36%

Mar 31, 2025

The Bollard Group, LLC

20.49M

1.39%

-242.40K

-1.17%

Mar 31, 2025

詳細を見る

98.180USD

Boston Scientific Corp

98.180

概要

企業名

金融

分析